高盛：欧康维视_2025 年中国医疗保健企业日 —— 关键要点
Goldman Sachs·2025-06-26 14:09
25 June 2025 | 7:10PM HKT Ocumension (1477.HK): China Healthcare Corporate Day 2025 — Key takeaways: Confident on OT-101, BD negotiation; FY25 sales to double Presenters: Tim Ruan - Chief Financial Officer Bottom line: Mgmt highlighted: 1) confidence on OT-101 (low dose atropine) with BD under negotiation, and 2) Yutiq supply to resume, FY25 guidance reiterated. Ziyi Chen +852-2978-0526 | ziyi.chen@gs.com Goldman Sachs (Asia) L.L.C. Linhai Zhao, Ph.D. +852-3966-4059 | linhai.zhao@gs.com Goldman Sachs (Asia) ...